Leptin-A (LepA) is a peptide hormone primarily produced in the liver and subcutaneous adipose tissue (SCAT) of Nile tilapia (Oreochromis niloticus), serving as a key regulator of energy homeostasis . Unlike mammals, teleost fish like tilapia possess two leptin paralogs (LepA and LepB), with LepA being the dominant isoform involved in nutrient metabolism and stress responses . Recombinant tilapia Leptin-A (rtLepA or NtrelepA) has been synthesized to study its metabolic roles, revealing conserved functions in appetite suppression, lipid/glucose catabolism, and adaptive responses to environmental stressors .
Acute intraperitoneal (i.p.) administration of rtLepA (400 ng/g body weight) reduces cumulative food intake by 30–50% within 7 hours in Nile tilapia .
This anorexigenic effect correlates with upregulated leptin receptor (LepR) and suppressor of cytokine signaling 3 (SOCS3) mRNA expression in the brain .
Lipid Metabolism: rtLepA increases hepatic expression of lipolysis genes (ATGL) and lipid transport markers (apoE) .
Glucose Metabolism: rtLepA enhances hepatic Glut2 expression, a key glucose transporter, and mobilizes glucose during hyperosmotic stress .
Leptin-A directly stimulates glycolysis through STAT3-dependent mechanisms:
| Parameter | Effect of rtLepA | Tissue/Cell Type | Source |
|---|---|---|---|
| gapdh mRNA | ↑ 2.25-fold | Pituitary rostral pars distalis (RPD) | |
| PFK activity | ↑ 1.5–2.0-fold | Hepatocytes | |
| Lactate secretion | ↑ 40–60% | Pituitary RPD & hepatocytes |
Insulin: Increases lepa mRNA by 70-fold in vivo, while rtLepA modulates insulin secretion depending on glucose levels .
Glucagon: Elevates lepa expression 18-fold, suggesting cross-talk between leptin and glucagon in glucose regulation .
Leptin resistance (LR) develops in tilapia under high-carbohydrate (HCD) or high-fat diets (HFD), but rtLepA retains selective metabolic effects:
HCD-DIO Fish: Maintains lipid metabolism activation but shows LR in glucose regulation .
HFD-DIO Fish: Exhibits reversed selectivity (LR in lipid metabolism but retained glucose regulation) .
Fasting for 1 week restores leptin sensitivity in both models .
During seawater acclimation:
Hepatic lepa expression increases 25-fold within 4 hours, depleting liver glycogen to elevate plasma glucose .
Cortisol synergizes with rtLepA to enhance glucose mobilization, critical for energy-demanding osmoregulation .
Therapeutic Potential: Targeting leptin-A pathways could address metabolic disorders in aquaculture .
Biotechnological Tools: Recombinant rtLepA production via E. coli systems enables large-scale functional studies .
Unanswered Questions: Mechanisms underlying tissue-specific leptin resistance and evolutionary conservation of STAT3-glycolytic pathways require further investigation .
The first six N-terminal amino acids of recombinant Tilapia leptin A are Ala-Pro-Leu-Pro-Val-Glu.
Leptin-A (LepA) is one of two leptin isoforms in tilapia (Oreochromis niloticus), with LepA being the dominant ortholog. The full-length cDNA of tilapia LepA (tLepA) is 486 bp, encoding a protein of 161 amino acids. Despite relatively low primary sequence homology with mammalian leptin, the three-dimensional structure of tLepA demonstrates strong conservation of tertiary structure, comprising 4 helices similar to human leptin . Tilapia has two leptin genes (lepA and lepB), whereas mammals typically have only one. This reflects the whole genome duplication event in teleost evolution. LepA appears to have retained most of the ancestral functions related to energy homeostasis in fish .
Unlike mammals where leptin is predominantly expressed in adipose tissue, tilapia LepA demonstrates high expression in both the liver and subcutaneous adipose tissue (SCAT) . Studies have verified comparable high expression levels of leptin in SCAT as in liver in Nile tilapia . This dual-site expression pattern differs from mammals and may reflect evolutionary adaptations in the regulation of energy metabolism in fish, which store lipids in multiple tissues including liver, muscle, and dispersed adipose deposits .
Leptin-A in tilapia serves several fundamental functions:
Appetite regulation: Intraperitoneal injection of recombinant tilapia LepA (NtrelepA) significantly reduces cumulative food intake 1-7 hours after treatment, confirming an acute anorexic effect similar to mammals .
Energy metabolism: LepA activates catabolism and promotes energy utilization in tilapia, particularly during periods of altered nutritional state .
Growth regulation: LepA interacts with the growth hormone (GH)/insulin-like growth factors (IGFs) axis. Recombinant tilapia LepA increases hepatic gene expression of igf-1, igf-2, ghr-1, and ghr-2 in isolated hepatocytes .
Glucose and lipid metabolism: LepA participates in regulating both glucose and lipid metabolism, though with selective actions depending on nutritional status .
Recombinant tilapia Leptin-A (rtLepA) is typically produced using an E. coli expression system. The process involves:
Obtaining the fragment encoding the mature protein of Nile tilapia Leptin A (Ala21-Cys161) with 6 tandem histidine residues at the N-terminal.
Digesting the fragment using restriction enzymes (NdeI and XhoI) and cloning it into an expression vector such as pET-32a (+).
Transforming the recombinant plasmid into E. coli competent cells (e.g., TransB (DE3)) using the heat shock method .
Commercial recombinant Leptin-A tilapia is available as a single, non-glycosylated polypeptide chain containing 161 amino acids with a molecular mass of 16,491 Dalton, purified using chromatographic techniques. For research applications, the lyophilized protein is typically reconstituted in sterile water or 0.4% NaHCO₃ adjusted to pH 8-9, with recommended concentrations not less than 100μg/ml .
The regulation of Leptin-A in tilapia shows interesting patterns that sometimes differ from mammals:
Fasting response: Circulating LepA levels and both lepa and lepr gene expression increase after 3-weeks of fasting and decline to control levels 10 days following refeeding . This pattern is opposite to mammals, where leptin levels typically decrease during fasting.
Diet-induced obesity: In diet-induced obesity (DIO) models, leptin resistance develops but with selective effects depending on the type of diet. High-carbohydrate diet (HCD) fish retain leptin action in lipid metabolism but show resistance in glucose metabolism regulation, while high-fat diet (HFD) fish show the reverse pattern .
Recovery from diet-induced resistance: Fasting DIO tilapia for 1 week completely recovers leptin actions in both lipid and glucose metabolism regulation, suggesting a reversible adaptive mechanism .
Dietary lipid effects: Increased dietary lipid supplementation significantly raises serum leptin levels in genetically improved farmed tilapia (GIFT) juveniles compared to control diets. The optimal dietary lipid level for specific growth rate (SGR) and feed conversion ratio (FCR) has been determined to be approximately 10.5% .
This metabolic regulation pattern suggests leptin in tilapia may function as an indicator of energy reserves rather than simply a satiety signal as in mammals .
Recent research provides evidence for a leptin-insulin axis in tilapia that shares functional similarities with the mammalian "adipoinsular axis" but with some important distinctions:
This bidirectional relationship provides important insights into the evolution of metabolic regulation in vertebrates .
Leptin resistance (LR) in diet-induced obesity (DIO) tilapia exhibits several intriguing characteristics:
Selective resistance: Unlike mammals where leptin resistance often affects multiple metabolic pathways, tilapia show selective leptin resistance depending on diet type:
Tissue-specific effects: The selective nature of leptin resistance suggests tissue-specific alterations in leptin signaling pathways, particularly in liver and adipose tissues .
Reversibility: A key finding is that fasting DIO tilapia for just one week completely recovers leptin action in both lipid and glucose metabolism regulation, indicating that the resistance mechanisms are highly adaptable and reversible .
Evolutionary significance: This selective regulation pattern may represent an adaptive mechanism that evolved to maximize energy storage when different nutrient types are abundant, allowing fish to store surplus calories efficiently regardless of whether they come from carbohydrates or fats .
These findings suggest that leptin may retain more activities in animals with leptin resistance than previously believed, challenging simplistic models of complete leptin signaling impairment in obesity .
Leptin-A in tilapia demonstrates significant interactions with the growth hormone (GH)/insulin-like growth factors (IGFs) axis:
Divergent regulation patterns: The pattern of leptin regulation by metabolic state in tilapia is similar to that observed for pituitary GH but opposite to that of hepatic GH receptor (GHR) and/or IGF dynamics. This suggests coordinated but distinct regulatory mechanisms governing these two systems .
Direct stimulation of growth factors: Recombinant tilapia LepA (rtLepA) directly increases hepatic gene expression of igf-1, igf-2, ghr-1, and ghr-2 in isolated hepatocytes following 24-hour incubation. This indicates leptin can directly modulate the expression of key components of the growth axis at the hepatic level .
Nutritional state coordination: The complementary patterns of regulation during fasting and refeeding suggest leptin and GH/IGF systems work together to coordinate energy allocation between metabolism and growth, optimizing survival during periods of nutritional stress .
Evolutionary conservation: These interactions appear to represent evolutionarily conserved mechanisms for coordinating energy status with growth potential, though the specific patterns may differ between fish and mammals .
This leptin-GH/IGF interaction provides a mechanism for tilapia to balance energy expenditure between immediate metabolic needs and long-term growth potential based on nutritional status .
Several complementary methodological approaches have proven effective for investigating leptin function in tilapia:
In vitro methods:
Isolated hepatocyte cultures: Effective for studying direct effects of recombinant leptin on gene expression of growth factors, receptors, and metabolic enzymes .
Isolated Brockmann bodies (pancreatic islets): Useful for examining leptin's effects on insulin and glucagon expression and secretion under controlled glucose concentrations .
In vivo methods:
Intraperitoneal (i.p.) injections: Administration of recombinant tilapia LepA (400 ng/g BW) has been effectively used to study acute effects on food intake and metabolism .
Dietary manipulation models: Creating high-carbohydrate diet (HCD) or high-fat diet (HFD) models to study diet-induced obesity and leptin resistance .
Fasting-refeeding protocols: Using controlled fasting periods (3 weeks) followed by refeeding to study dynamic regulation of leptin and associated pathways .
Molecular techniques:
Gene expression analysis: Quantitative PCR to measure expression of lepa, lepb, and lepr in various tissues .
Protein quantification: ELISA or other immunological methods to measure circulating leptin levels .
Metabolic parameters assessment: Measuring growth parameters (SGR, FCR), nucleic acids, and metabolic indicators to correlate with leptin function .
The combination of both in vitro and in vivo approaches, coupled with molecular analyses, provides the most comprehensive understanding of leptin function in tilapia .
Tilapia leptin research offers valuable insights for comparative endocrinology:
These comparative aspects highlight how tilapia serves as an excellent model for understanding the evolution of energy homeostasis mechanisms across vertebrates .
Researchers face several technical challenges when studying leptin signaling in tilapia:
Species-specific reagents: The limited availability of species-specific antibodies and assay reagents often necessitates developing custom tools or validating cross-reactivity with commercially available options. Using recombinant tilapia leptin rather than mammalian leptin is crucial for physiologically relevant results .
Stability and handling of recombinant protein: Recombinant tilapia Leptin-A requires careful handling, with specific reconstitution protocols using 0.4% NaHCO₃ adjusted to pH 8-9. Even with proper handling, lyophilized Leptin-A remains stable at room temperature for only about 3 weeks and reconstituted protein should be stored at 4°C for short periods (2-7 days) or below -18°C for longer storage .
Tissue sampling limitations: The small size of specific tissues (like Brockmann bodies) and the dispersed nature of adipose tissue in fish present challenges for obtaining sufficient material for analysis .
Diverse lipid storage sites: Unlike mammals where adipose tissue is the primary lipid storage site, tilapia store lipids in multiple tissues including liver, muscle, and dispersed adipose deposits, complicating the study of lipid metabolism .
Diet formulation and feeding regimens: Creating standardized experimental diets with precise nutrient compositions is critical for studies on diet-induced obesity and leptin resistance but requires specialized expertise in fish nutrition .
Addressing these challenges requires careful experimental design and often the development of custom methodologies tailored to tilapia physiology .
When encountering contradictory data between fish species and mammals, researchers should consider:
Evolutionary context: Teleost fish and mammals diverged approximately 450 million years ago, with teleosts undergoing an additional whole-genome duplication event. This resulted in two leptin paralogs (LepA and LepB) in most fish species compared to a single leptin gene in mammals. These evolutionary differences may underlie functional divergence .
Environmental adaptations: Fish inhabit aquatic environments with different energetic challenges than terrestrial mammals, potentially leading to fundamentally different metabolic strategies. For instance, the opposite regulation of leptin during fasting between fish and mammals may reflect different strategies for energy mobilization in these environments .
Methodological considerations: Contradictions may arise from:
Selective pressures on energy storage: Fish typically experience more variable food availability in natural environments than laboratory mammals, potentially selecting for different leptin signaling strategies .
Data integration approach: Rather than viewing contradictions as experimental failures, researchers should use them to develop more nuanced models of leptin function that incorporate evolutionary divergence and convergence across vertebrate lineages .
This interpretive framework allows researchers to reconcile apparently contradictory findings and develop more comprehensive models of leptin function across vertebrates .
Critical control measures for leptin-metabolism studies in tilapia include:
Baseline physiological parameters:
Nutritional status standardization:
Appropriate controls for recombinant protein administration:
Environmental parameters:
Methodology validation:
These control measures strengthen experimental rigor and increase the reliability of data on leptin's metabolic effects in tilapia .
Optimal dietary formulations for studying leptin function in tilapia vary by research context:
Standard/Control Diets:
Balanced formulation: Iso-nitrogenous diets with approximately 34% dietary protein and moderate lipid levels (3-6%) represent appropriate baseline diets .
Low-lipid control: For lipid supplementation studies, a baseline diet containing minimal lipid (0.35%) without additional lipid supplementation serves as an effective control .
High-Carbohydrate Diet (HCD) for DIO Models:
These diets typically feature elevated digestible carbohydrates while maintaining protein content
Useful for studying selective leptin resistance in glucose metabolism
High-Fat Diet (HFD) for DIO Models:
Diets supplemented with fish oil to reach lipid levels of 9-15% while maintaining iso-nitrogenous formulation
Effective for studying leptin resistance in lipid metabolism
Graded Lipid Series:
For dose-response studies, a series of diets with incrementally increasing lipid levels provides valuable insights:
Control diet (0.35% lipid)
Incrementally increased levels (e.g., 3.35%, 6.35%, 9.35%, 12.35%, and 15.35% lipid)
Based on second-order polynomial regression analysis, optimal dietary lipid levels of approximately 10.5% produce optimal growth performance
Diet Preparation Considerations:
Use high-quality ingredients with consistent composition
Ensure homogeneous mixing of supplements
Properly store diets to prevent oxidation of lipids
These formulations provide appropriate experimental frameworks for investigating leptin's role across different nutritional contexts in tilapia .
Effective measurement and interpretation of leptin signaling in tilapia requires multi-level analysis:
Transcriptional Analysis:
Gene expression profiling: Quantitative PCR for key components:
Tissue selection is critical:
Protein Level Assessment:
Circulating leptin: Immunological assays calibrated for tilapia leptin
Receptor expression: Analysis of membrane fractions for leptin receptor proteins
Post-translational modifications: Phosphorylation status of key signaling components
Functional Outputs:
Metabolic parameters:
Growth metrics:
Integrated Data Interpretation:
Time-course analysis: Distinguish between acute (1-7 hours) and chronic (days to weeks) effects of leptin
Context-dependent effects: Interpret data within specific nutritional contexts (fasting, refeeding, DIO models)
Comparative approach: Reference findings against established patterns in mammals to identify conserved versus divergent mechanisms
Statistical modeling: Use appropriate models for complex interactions:
This comprehensive approach allows researchers to effectively track signaling pathway changes and interpret them within relevant physiological contexts .
| Parameter | Control Diet (0.35% lipid) | Optimal Lipid Diet (~10.5%) | High Lipid Diet (15.35%) | Statistical Significance |
|---|---|---|---|---|
| SGR (% day⁻¹) | 1.92 ± 0.11 | 2.43 ± 0.09 | 2.31 ± 0.10 | p < 0.05 |
| FCR | 2.11 ± 0.14 | 1.73 ± 0.08 | 1.81 ± 0.12 | p < 0.05 |
| HSI (%) | 2.87 ± 0.23 | 2.17 ± 0.19 | 2.09 ± 0.21 | p < 0.05 |
| Crude protein (%) | 19.35 ± 0.87 | 17.89 ± 0.73 | 17.42 ± 0.79 | p < 0.05 |
| Crude fat (%) | 5.43 ± 0.41 | 8.76 ± 0.57 | 9.32 ± 0.63 | p < 0.05 |
| Serum leptin level | Low | Significantly elevated | Significantly elevated | p < 0.05 |
| LepR gene expression | High | Significantly reduced | Significantly reduced | p < 0.05 |
| AdipoRs 1 & 2 expression | Low | Significantly elevated | Significantly elevated | p < 0.05 |
Data compiled from search result , showing significant effects of dietary lipid supplementation on growth, body composition, and hormone parameters compared to control diet. SGR = specific growth rate; FCR = feed conversion ratio; HSI = hepatosomatic index; LepR = leptin receptor; AdipoRs = adiponectin receptors.
| Parameter | Fed Controls | 3-Week Fasting | 10-Day Refeeding | Pattern |
|---|---|---|---|---|
| Circulating LepA | Baseline | Increased | Return to baseline | ↑ during fasting |
| lepa expression | Baseline | Increased | Return to baseline | ↑ during fasting |
| lepr expression | Baseline | Increased | Return to baseline | ↑ during fasting |
| Pituitary GH | Baseline | Increased | Return to baseline | ↑ during fasting |
| Hepatic GHR | Baseline | Decreased | Return to baseline | ↓ during fasting |
| Hepatic IGFs | Baseline | Decreased | Return to baseline | ↓ during fasting |
Data compiled from search result , showing the pattern of leptin regulation by metabolic state is similar to that observed for pituitary GH but opposite to that of hepatic GHR and IGF dynamics in tilapia. GH = growth hormone; GHR = growth hormone receptor; IGFs = insulin-like growth factors.
This data demonstrates that leptin significantly impacts growth performance, body composition, and metabolic regulation in tilapia, with its effects being strongly influenced by nutritional status .
| Parameter | HCD-DIO Model | HFD-DIO Model | After 1-Week Fasting |
|---|---|---|---|
| Glucose Metabolism | |||
| Leptin sensitivity | Resistant | Sensitive | Fully recovered |
| Blood glucose regulation | Impaired response to leptin | Maintained response to leptin | Normal response |
| Hepatic glucose metabolism genes | Resistant to leptin stimulation | Responsive to leptin stimulation | Fully responsive |
| Lipid Metabolism | |||
| Leptin sensitivity | Sensitive | Resistant | Fully recovered |
| Lipolysis activation | Maintained response to leptin | Impaired response to leptin | Normal response |
| Lipogenic enzyme regulation | Responsive to leptin | Resistant to leptin | Fully responsive |
| Food Intake | |||
| Acute anorexigenic effect | Partially impaired | Partially impaired | Normalized |
| Tissue Distribution of Leptin Expression | |||
| Liver expression | Elevated | Elevated | Normalized |
| SCAT expression | Elevated | Elevated | Normalized |
Data compiled from search results , demonstrating the selective nature of leptin resistance in different DIO models and the complete recovery after fasting. HCD = high-carbohydrate diet; HFD = high-fat diet; DIO = diet-induced obesity; SCAT = subcutaneous adipose tissue.
This table highlights the remarkable finding that leptin resistance in tilapia is nutrient-specific rather than systemic, with HCD-DIO fish maintaining leptin sensitivity in lipid metabolism while developing resistance in glucose metabolism regulation, and HFD-DIO fish showing the reverse pattern . This selective regulation represents a potential evolutionary adaptation allowing fish to store surplus calories efficiently regardless of whether they come from carbohydrates or fats .
| Parameter | Tilapia | Mammals | Evolutionary Implication |
|---|---|---|---|
| Leptin Effects on Insulin | |||
| At basal glucose | Decreases insa | Inhibits insulin secretion | Partially conserved |
| At high glucose | Increases insa | Inhibits insulin secretion | Divergent - more dynamic in fish |
| Insulin Effects on Leptin | |||
| In vitro effect | 2.5-fold increase in lepa | Stimulates leptin release | Conserved function |
| In vivo effect | 70-fold increase in lepa | Stimulates leptin release | Conserved but enhanced magnitude in fish |
| Glucagon Interactions | |||
| Effect on leptin | Increases lepa (18-fold in vivo) | Less prominent role | Unique aspect in fish |
| Leptin effect on glucagon | Variable effects on glub | Suppresses glucagon | Divergent regulation |
| Glycemic Regulation | |||
| Glucose fluctuation tolerance | Wider tolerance range | Narrow physiological range | Reflects different metabolic needs |
| Fasting response | Increased leptin | Decreased leptin | Fundamentally different strategy |
Data compiled from search result , showing evidence for a leptin-insulin axis in tilapia that shares functional similarities with mammals but exhibits more dynamic and flexible relationships. insa = insulin gene a; glub = glucagon gene b.
This comparative analysis reveals that while a leptin-insulin regulatory axis exists in both tilapia and mammals, the teleost version appears more dynamic and adaptable, likely reflecting the different metabolic demands and energy storage strategies between aquatic ectotherms and terrestrial endotherms . The conservation of this axis across such evolutionary distance (approximately 450 million years) suggests it represents a fundamental vertebrate mechanism for coordinating energy homeostasis .
In tilapia (Oreochromis niloticus), two leptin sequences, tLepA and tLepB, along with one leptin receptor sequence (tLepR), have been identified . The full-length cDNA of tLepR encodes a protein of 1140 amino acids, containing all functionally important domains conserved among vertebrate leptin receptors . The cDNAs of tLepA and tLepB encode proteins of 161 and 152 amino acids, respectively .
Leptin-A in tilapia has been shown to regulate various biological processes. For instance, it stimulates cellular glycolysis through a STAT3-dependent mechanism . Transcriptomic analysis of prolactin cells in the tilapia pituitary revealed that rtLepA differentially regulates 1,995 genes, influencing numerous cellular gene networks, including metabolism, protein processing, transport, and cell cycle . Leptin-A also stimulates the expression of glycolytic enzymes such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 6-phosphofructo-1-kinase (PFK1), enhancing glycolytic output .
Recombinant Leptin-A Tilapia is biologically active in promoting the proliferation of BAF/3 cells stably transfected with the long form of the human leptin receptor, although its activity is lower than that of mammalian leptin . It is also active in promoting STAT-LUC activation in COS7 cells transfected with the tilapia leptin receptor .
For practical applications, the lyophilized form of Leptin-A Tilapia is stable at room temperature for three weeks but should be stored desiccated below -18°C for long-term storage . Upon reconstitution, it should be stored at 4°C for short-term use and below -18°C for future use, with the addition of a carrier protein to prevent freeze-thaw cycles .